Bolus injection of adenosine before cardioplegic induction improves postischemic global function in coronary artery bypass grafting

Acta Anaesthesiologica Taiwanica

Volumn 43, Issue 4, 2005, Pages 197-204

  Chen, Chen Hsiu ^a,b   Kang, Pei Leun ^a   Chang, Ting Hang ^a   Lo, Anna ^a   Ye, Xuan De ^a   Lee, Ming Chien ^a   Liu, Kang ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Adenosine; Cardiopulmonary bypass; Heart arrest; Induced

Indexed keywords

ADENOSINE; BICARBONATE; DOPAMINE; FENTANYL; HEART ENZYME; INOTROPIC AGENT; ISOFLURANE; MANNITOL; MIDAZOLAM; OXYGEN; PANCURONIUM; PLACEBO; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; ST THOMAS HOSPITAL SOLUTION; TROPONIN I;

ADULT; AGED; ANESTHESIA; AORTA CLAMPING; AORTA ROOT; ARTICLE; ASYSTOLE; BOLUS INJECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE REGIMEN; ELECTIVE SURGERY; ENZYME ASSAY; ENZYME RELEASE; FEMALE; HEART ARREST; HEART FUNCTION; HEART HEMODYNAMICS; HEART INDEX; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART PROTECTION; HUMAN; MALE; MEDICAL DOCUMENTATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADULT; AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HEART ARREST, INDUCED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; PROSPECTIVE STUDIES;

EID: 30544442179     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Menasche P: Strategies to improve myocardial protection during extracorporeal circulation. Shock 16 (Suppl 1):20-23, 2001.
2. Mentzer RM Jr, Birjiniuk V, Khuri S, Lowe JE, Rahko PS, Weisel RD, Wellons HA, Barker ML, Lasley RD: Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 229:643-650, 1999.
3. Chauhan S, Wasir HS, Bhan A, Rao BH, Saxena N, Venugopal P: Adenosine for cardioplegic induction: a comparison with St Thomas solution. J Cardiothorac Vasc Anesth 14:21-24, 2000.
4. Mentzer RM, Bunger R, Lasley RD: Adenosine enhanced preservation of myocardial function and energetics. Possible involvement of adenosine A1 receptor system. Cardiovasc Res 27:28-35, 1993.
5. Liu CS, Thorton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM: Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350-356, 1991.
6. Liu G, Richards SC, Olsson RA, Mullane K, Walsh RS, Downey JM: Evidence that adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28:1057-1061, 1994.
7. Zarro DL, Palanzo DA, Sadr FS: Myocardial preconditioning using adenosine: review and clinical experience. Perfusion 13:145-150, 1998.
8. Lestin M, Hergert M, Lestin HG, Brinker C, Storm H, Kuhrt E, Kuhrt B, Lambrecht HG, Kuhnel W: Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin Lab 48: 211-221, 2002.
9. Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C: The steady-state TTX-sensitive ('window') sodium current in cardiac Purkinje fibers. Pflugers Arch 379:137-142, 1979.
10. Chambers DJ: Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 75:S661-666, 2003.
11. de Jong JW, de Jonge R, Keijzer E, Bradamante S: The role of adenosine in preconditioning. Pharmacol Ther 87:141-149, 2000.
12. Chamber DJ: Polarization and myocardial protection. Curr Opin Cardiol 14:495-501, 1999.
13. Wilbur SL, Marchlinski FE: Adenosine as an antiarrhythmic agent. Am J Cardiol 79:30-37, 1997.
14. Hori M, Kitakaza M: Adenosine, the heart and coronary circulation. Hypertension 18:565-574, 1991.
15. Mullane K, Bullough D: Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol 27:1041-1054, 1995.
16. Mubagwa K, Mullane K, Flameng W: Role of adenosine in the heart and circulation. Cardiovasc Res 32:797-813, 1996.
17. Tombs CF, McGee S, Johnston WE, Vinten-Johansen J: Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86:986-994, 1992.
18. Hudspeth DA, Nakanishi K, Vinten-Johansen J, Zhao ZQ, McGee DS, Williams MW, Hammon JW Jr: Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg 58:1637-1644, 1994.
19. Schubert T, Herbert V, Owen P, Reichart B, Opie LH: Adenosine cardioplegia, adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg 98:1057-1065, 1989.
20. Jacquet L, Noirhomme P, El Khoury G, Goenen M, Philippe M, Col J, Dion R: Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg 13:378-384, 1998.
21. Wei M, Kuukasjarvi P, Laurikka J, Honkonen EL, Kaukinen S, Laine S, Tarkka M: Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting. Chest 120:860-865, 2001.
22. Belhomme D, Peynet J, Florens E, Tibourtine O, Kitakaze M, Menasche P: Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann Thorac Surg 70: 590-594, 2000.